Login / Signup

Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study.

Gudrun FleischhackM MassiminoM Warmuth-MetzE KhuhlaevaG JanssenN GrafS RutkowskiA BeilkenI SchmidV BiassoniS K GorelishevC KrammH ReinhardP G SchlegelR-D KortmannD ReuterF BachN E Iznaga-EscobarU Bode
Published in: Journal of neuro-oncology (2019)
Concomitant treatment with RT and nimotuzumab was feasible in an outpatient setting. The PFS and OS were comparable to results achieved with RT and intensive chemotherapy in hospitalized setting.
Keyphrases
  • phase iii
  • newly diagnosed
  • clinical trial
  • open label
  • early stage
  • locally advanced
  • radiation therapy
  • squamous cell carcinoma
  • randomized controlled trial
  • low grade
  • radiation induced
  • phase ii
  • study protocol